Exploring the Validity of Valproic Acid Animal Model of Autism
about
Transplantation of mesenchymal stem cells reverses behavioural deficits and impaired neurogenesis caused by prenatal exposure to valproic acid.Valproic Acid Exposure during Early Postnatal Gliogenesis Leads to Autistic-like Behaviors in Rats.Prenatal Valproate Exposure Differentially Affects Parvalbumin-Expressing Neurons and Related Circuits in the Cortex and Striatum of Mice.Vitamin D treatment during pregnancy prevents autism-related phenotypes in a mouse model of maternal immune activationLessons learned from studying syndromic autism spectrum disorders.Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism.The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models.Congenital malformation and autism spectrum disorder: Insight from a rat model of autism spectrum disorder.Effect of early postnatal exposure to valproate on neurobehavioral development and regional BDNF expression in two strains of mice.Altered attentional processing in male and female rats in a prenatal valproic acid exposure model of autism spectrum disorder.Neural mechanisms underlying GABAergic regulation of adult hippocampal neurogenesis.17-β estradiol increases parvalbumin levels in Pvalb heterozygous mice and attenuates behavioral phenotypes with relevance to autism core symptoms.Resveratrol Prevents Cellular and Behavioral Sensory Alterations in the Animal Model of Autism Induced by Valproic Acid.Evidence for Brainstem Contributions to Autism Spectrum DisordersSex-specific Behavioral Features of Rodent Models of Autism Spectrum Disorder
P2860
Q33566524-27DA05A9-4B65-4EB9-A5AF-642539B8896BQ37373687-3C193D91-D5E8-45CD-B4CB-2632DC5AC501Q37521380-01B93B65-B54A-4378-9648-93269D120475Q37700976-DDD28218-9CC8-477D-A7C7-72EB6F1F1F27Q38992291-273C228A-2C0E-404D-A853-1663C42DFFD0Q39324090-137AA552-2A93-4690-8062-AD54E7C2A124Q41660878-D40683F1-539B-4163-9105-B3CE29732184Q42375091-17AF80B5-F524-47ED-9207-78BF9F490A4BQ47327174-DD8DE7B0-7B86-449A-87DD-222978C890CFQ47634845-5BE58F46-3F21-4289-AB4F-2B0308E4F74CQ48096664-4C6B8D2D-392D-4083-BD03-2399653B4AEEQ50418421-00BD12CB-DD4B-4AC1-84B2-74EAAD0CB808Q55340060-3DC49460-0736-46EC-8A83-60F1031786C7Q58583908-233A14D9-2F53-41AF-9B29-EEB8758585ABQ59133547-145CC37A-1E51-47B1-9387-B0DB3ACC73B9
P2860
Exploring the Validity of Valproic Acid Animal Model of Autism
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Exploring the Validity of Valproic Acid Animal Model of Autism
@ast
Exploring the Validity of Valproic Acid Animal Model of Autism
@en
Exploring the Validity of Valproic Acid Animal Model of Autism
@nl
type
label
Exploring the Validity of Valproic Acid Animal Model of Autism
@ast
Exploring the Validity of Valproic Acid Animal Model of Autism
@en
Exploring the Validity of Valproic Acid Animal Model of Autism
@nl
prefLabel
Exploring the Validity of Valproic Acid Animal Model of Autism
@ast
Exploring the Validity of Valproic Acid Animal Model of Autism
@en
Exploring the Validity of Valproic Acid Animal Model of Autism
@nl
P2093
P2860
P3181
P356
P1476
Exploring the Validity of Valproic Acid Animal Model of Autism
@en
P2093
Chan Young Shin
Darine Froy N Mabunga
Edson Luck T Gonzales
Ji-Woon Kim
Ki Chan Kim
P2860
P304
P3181
P356
10.5607/EN.2015.24.4.285
P407
P577
2015-12-16T00:00:00Z